Gloria Wong

1.1k total citations
14 papers, 662 citations indexed

About

Gloria Wong is a scholar working on Pharmacology, Applied Microbiology and Biotechnology and Epidemiology. According to data from OpenAlex, Gloria Wong has authored 14 papers receiving a total of 662 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pharmacology, 7 papers in Applied Microbiology and Biotechnology and 6 papers in Epidemiology. Recurrent topics in Gloria Wong's work include Antibiotics Pharmacokinetics and Efficacy (9 papers), Antibiotic Use and Resistance (7 papers) and Pneumonia and Respiratory Infections (4 papers). Gloria Wong is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (9 papers), Antibiotic Use and Resistance (7 papers) and Pneumonia and Respiratory Infections (4 papers). Gloria Wong collaborates with scholars based in Australia, United States and France. Gloria Wong's co-authors include Jeffrey Lipman, Jason A. Roberts, Jacobus Ungerer, Brett McWhinney, Scott Briscoe, Syamhanin Adnan, Fekade B. Sime, Leiming Guo, Ashwni Verma and Aman P. Singh and has published in prestigious journals such as Antimicrobial Agents and Chemotherapy, Journal of Pharmacology and Experimental Therapeutics and Journal of Antimicrobial Chemotherapy.

In The Last Decade

Gloria Wong

13 papers receiving 649 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Gloria Wong Australia	12	527	292	184	182	96	14	662
Fleur Wolff Belgium	16	393 0.7×	222 0.8×	141 0.8×	121 0.7×	93 1.0×	49	931
Fabien Xuereb France	12	319 0.6×	238 0.8×	79 0.4×	134 0.7×	48 0.5×	42	605
Ariadna Padullés Spain	11	213 0.4×	227 0.8×	86 0.5×	174 1.0×	63 0.7×	49	560
Sarah Djabarouti France	13	346 0.7×	261 0.9×	51 0.3×	147 0.8×	67 0.7×	28	636
Susan Raber United States	14	283 0.5×	168 0.6×	47 0.3×	99 0.5×	51 0.5×	33	628
Julie Passarell United States	14	526 1.0×	285 1.0×	101 0.5×	347 1.9×	141 1.5×	38	909
Guojun Yuan United States	7	438 0.8×	269 0.9×	229 1.2×	452 2.5×	74 0.8×	18	925
Iris K. Minichmayr Austria	12	458 0.9×	235 0.8×	88 0.5×	137 0.8×	77 0.8×	31	594
Jiao Xie China	18	378 0.7×	258 0.9×	74 0.4×	191 1.0×	98 1.0×	54	888
Ryan L. Crass United States	12	315 0.6×	132 0.5×	68 0.4×	136 0.7×	76 0.8×	33	485

Countries citing papers authored by Gloria Wong

Since Specialization

Citations

This map shows the geographic impact of Gloria Wong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gloria Wong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gloria Wong more than expected).

Fields of papers citing papers by Gloria Wong

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gloria Wong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gloria Wong. The network helps show where Gloria Wong may publish in the future.

Co-authorship network of co-authors of Gloria Wong

This figure shows the co-authorship network connecting the top 25 collaborators of Gloria Wong. A scholar is included among the top collaborators of Gloria Wong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gloria Wong. Gloria Wong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Trivedi, Jitendra K., Nicole Gavin, & Gloria Wong. (2025). Polypharmacy and super‐polypharmacy in non‐geriatric, adult populations: a scoping review of characteristics, risks, and deprescribing frameworks. Journal of Pharmacy Practice and Research. 56(1). 62–75.

Heffernan, Aaron J., Fekade B. Sime, Steven C. Wallis, et al.. (2022). Multicenter Population Pharmacokinetic Study of Unbound Ceftriaxone in Critically Ill Patients. Antimicrobial Agents and Chemotherapy. 66(6). e0218921–e0218921. 17 indexed citations

Wong, Gloria. (2022). Pharmacological management of chronic non-cancer pain in frail older people. Australian Prescriber. 45(1). 2–7. 8 indexed citations

Jager, Nynke G L, Reinier M. van Hest, Jiao Xie, et al.. (2020). Optimization of flucloxacillin dosing regimens in critically ill patients using population pharmacokinetic modelling of total and unbound concentrations. Journal of Antimicrobial Chemotherapy. 75(9). 2641–2649. 22 indexed citations

Singh, Aman P., Leiming Guo, Ashwni Verma, et al.. (2020). Antibody Coadministration as a Strategy to Overcome Binding-Site Barrier for ADCs: a Quantitative Investigation. The AAPS Journal. 22(2). 28–28. 54 indexed citations

Singh, Aman P., Gail M. Seigel, Leiming Guo, et al.. (2020). Evolution of the Systems Pharmacokinetics-Pharmacodynamics Model for Antibody-Drug Conjugates to Characterize Tumor Heterogeneity and In Vivo Bystander Effect. Journal of Pharmacology and Experimental Therapeutics. 374(1). 184–199. 24 indexed citations

Wong, Gloria, Fabio Silvio Taccone, Paola Villois, et al.. (2019). β-Lactam pharmacodynamics in Gram-negative bloodstream infections in the critically ill. Journal of Antimicrobial Chemotherapy. 75(2). 429–433. 43 indexed citations

Singh, Aman P., Leiming Guo, Ashwni Verma, Gloria Wong, & Dhaval K. Shah. (2019). A Cell-Level Systems PK-PD Model to Characterize In Vivo Efficacy of ADCs. Pharmaceutics. 11(2). 98–98. 14 indexed citations

Wong, Gloria, Scott Briscoe, Brett McWhinney, et al.. (2018). Therapeutic drug monitoring of β-lactam antibiotics in the critically ill: direct measurement of unbound drug concentrations to achieve appropriate drug exposures. Journal of Antimicrobial Chemotherapy. 73(11). 3087–3094. 128 indexed citations

10.

Wong, Gloria, et al.. (2017). Impact of β-lactam antibiotic therapeutic drug monitoring on dose adjustments in critically ill patients undergoing continuous renal replacement therapy. International Journal of Antimicrobial Agents. 49(5). 589–594. 49 indexed citations

11.

Alobaid, Abdulaziz S., Alexander Brinkmann, Otto Frey, et al.. (2015). What is the effect of obesity on piperacillin and meropenem trough concentrations in critically ill patients?. Journal of Antimicrobial Chemotherapy. 71(3). 696–702. 30 indexed citations

12.

Wong, Gloria, Fekade B. Sime, Jeffrey Lipman, & Jason A. Roberts. (2014). How do we use therapeutic drug monitoring to improve outcomes from severe infections in critically ill patients?. BMC Infectious Diseases. 14(1). 288–288. 73 indexed citations

13.

Wong, Gloria, et al.. (2014). Comparison of the Accuracy and Precision of Pharmacokinetic Equations To Predict Free Meropenem Concentrations in Critically Ill Patients. Antimicrobial Agents and Chemotherapy. 59(3). 1411–1417. 25 indexed citations

14.

Wong, Gloria, Scott Briscoe, Syamhanin Adnan, et al.. (2013). Protein Binding of β-Lactam Antibiotics in Critically Ill Patients: Can We Successfully Predict Unbound Concentrations?. Antimicrobial Agents and Chemotherapy. 57(12). 6165–6170. 175 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact